Highlights and Quick Summary
- Annual ROA for 2022 was -38.76% (a -62.46% decrease from previous year)
- Annual ROA for 2021 was -103.25% (a -Infinity% decrease from previous year)
- Annual ROA for 2020 was 0.0% (a NaN% decrease from previous year)
- Twelve month ROA ending September 30, 2023 was -76.18% (a -32.33% decrease compared to previous quarter)
- Twelve month trailing ROA increased by 15.58% year-over-year
Trailing ROA for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| -76.18% | -112.57% | -95.5% | -65.91% |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROA of Prime Medicine, Inc.
Most recent ROAof PRME including historical data for past 10 years.Interactive Chart of ROA of Prime Medicine, Inc.
Prime Medicine, Inc. ROA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -38.76% |
| 2021 | – | – | – | – | -103.25% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology